What is myositis clinical trials consortium (MCTC)?
MCTC is a collaborative international alliance dedicated to facilitating, coordinating, and conducting clinical trials and related supportive clinical research in idiopathic inflammatory myopathies (IIM).
This partnership works to advance the discovery of effective treatments for autoimmune myositis by integrating a diverse group of clinical investigators, researchers, medical centers, research staff, and other key stakeholders.
MCTC focus on various subtype of myositis, including polymyositis (PM), immune necrotizing myopathy (IMNM), dermatomyositis (DM), amyopathic dermatomyositis (CADM), anti-synthetase syndrome (ASS), juvenile myositis, cancer-associated autoimmune myositis, connective-tissue disease associated myositis, and inclusion body myositis (IBM).
NEWS
2025 Oct
We will provide travel grants to support the participation of early-career investigators at GCOM 2026!
– Deadline for applications: November 1, 2025.
– Notification of awardees: December 1, 2025.
Download the Application Instruction for More Detail!
2025 Sep
We’re delighted to announce our partnership with Myositis UK!
Together, we’ll strengthen patient support, promote education, and collaborate to advance clinical trials in myositis.
2025 Sep
At Asia Pacific League of Associations for Rheumatology (APLAR) conference, Dr. Iris Tang presented the “Global Patterns and Challenges in Patient Recruitment for Idiopathic Inflammatory Myopathy Clinical Trials ” and Dr. Ting-Yuan Lan presented the “Gaps in Training and Expertise in Myositis Outcome Measures” on behalf of MCTC.
2025 July
We’re excited to share that MCTC has received new support from Nori’s Fight, further empowering our mission to improve the lives of people with myositis. This support strengthens our efforts to close critical gaps in physician expertise and enhance patient recruitment—two major challenges in advancing clinical trials with innovative and effective treatments.
Our mission
Facilitate clinical trial planning, including study feasibility and site selection.
Offer junior investigators/centers comprehensive training in study protocol, disease classification and assessment, and outcome measures to establish the readiness for further myositis clinical trials and research.
Develop a multi-center prospective observational myositis registry with data collection at individual centers for future myositis clinical trials and related research.
Provide preliminary analysis, feasibility assessments, collaboration and grant support for participating investigators.
Establish collaborative clinical trials and related studies among various participating centers, such as to develop and validate novel classification criteria and outcome measures for future myositis clinical trials.
Generate interdisciplinary discussion and consensus on standards for myositis clinical trial design, protocols, guidelines, ethics, and outcome measures.
Want to join or support Myositis clinical trials and studies?
Myositis Clinical Trial Consortium (MCTC) is open to investigators , study coordinators and study team members, patients and patient support organizations, and industry partners who are interested in participating in myositis clinical trials and research.